Search results
People also ask
What is nifurtimox used for?
Is nifurtimox available in oral form?
What is nifurtimox (lampit)?
Is nifurtimox FDA approved?
Nifurtimox, sold under the brand name Lampit, is a medication used to treat Chagas disease and sleeping sickness. [2] [4] For sleeping sickness it is used together with eflornithine in nifurtimox-eflornithine combination treatment. [4] . In Chagas disease it is a second-line option to benznidazole. [5] . It is given by mouth. [2]
Save. Nifurtimox. Generic name: nifurtimox [ nye-FURE-ti-mox ] Brand name: Lampit. Dosage form: oral tablet (120 mg; 30 mg) Drug class: Miscellaneous antibiotics. Medically reviewed by Drugs.com on Mar 13, 2023. Written by Cerner Multum. Uses. Side effects. Warnings. Before taking. Dosage. Interactions. What is nifurtimox?
Oct 20, 2016 · Brand Names. Lampit. Generic Name. Nifurtimox. DrugBank Accession Number. DB11820. Background. Chagas disease, caused by a parasite known as Trypanosoma cruzi (T.cruzi), is a vector-transmitted disease affecting animals and humans in the Americas. It is commonly known as American Trypanosomiasis. 11.
Nifurtimox is used to treat Chagas disease (an infection caused by a parasite) in children from birth to 18 years old who weigh at least 5.5 pounds (2.5 kg). Nifurtimox is in a class of medications called antiprotozoals. It works by killing the organism that can cause Chagas disease.
Description and Brand Names. Drug information provided by: Merative, Micromedex® US Brand Name. Lampit; Descriptions. Nifurtimox is used to treat Chagas disease (American Trypanosomiasis) in children.
Nifurtimox | C10H13N3O5S | CID 6842999 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.
Nifurtimox. In Meyler's Side Effects of Drugs (Sixteenth Edition), 2016. General information. Nifurtimox is used to treat Chagas’ disease (American trypanosomiasis) [1, 2].For treatment of the acute phase and in congenital cases the recommended dosage is 8–10 mg/kg/day, divided into two or three daily doses, for 30–60 consecutive days.
